BioMarin Pharmaceutical Inc. (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
5/20/2013
More...
|
Progenics Pharmaceuticals, Inc. (PGNX) Added to the NASDAQ Biotechnology Index
5/20/2013
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) Added to NASDAQ Biotechnology Index
5/20/2013
More...
|
CytRx Corporation (CYTR) Issues Letter to Stockholders Providing Business Update
5/20/2013
More...
|
TNI BioTech's CEO Issues Letter to Shareholders Discussing Recent Events
5/17/2013
More...
|
Stemline Therapeutics, Inc. (STML) Prices $60 Million Public Offering of Common Stock
5/17/2013
More...
|
Hyperion Therapeutics Added to NASDAQ Biotechnology Index (NBI)
5/17/2013
More...
|
Vertex Pharmaceuticals (MA) (VRTX) Calls for Redemption of $400 Million in Convertible Senior Subordinated Notes Due 2015
5/17/2013
More...
|
Bristol-Myers Squibb Company (BMY) Announces Intention to Voluntarily Delist Preferred Stock
5/17/2013
More...
|
Oxygen Biotherapeutics, Inc. (OXBO) Receives Favorable NASDAQ Listing Decision
5/17/2013
More...
|
PURE Bioscience (PURE) Stock to Begin Trading on the OTCQB Marketplace
5/17/2013
More...
|
Galapagos NV (GLPG.BR) Creates New Warrant Plan
5/17/2013
More...
|
VIVUS, Inc. (VVUS) Announces Pricing of Offering of $220 Million of 4.50% Convertible Senior Notes
5/16/2013
More...
|
Lundbeck Inc. (LUN.CO) Increases its Share Capital by 9,772 Shares (0.005% of Outstanding Shares) as a Result of Employee Warrant Exercise
5/16/2013
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces $20 Million Underwritten Offering
5/16/2013
More...
|
Annual General Meeting of Active Biotech AB (BTPC)
5/16/2013
More...
|
Bavarian Nordic (BAVA.CO) - Interim Financial Report for the Period 1 January to 31 March 2013
5/16/2013
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces Proposed Public Offering of Common Stock
5/16/2013
More...
|
Oxygen Biotherapeutics, Inc. (OXBO) Receives Favorable NASDAQ Listing Decision
5/16/2013
More...
|
Elan Corporation PLC (ELN) Announces Publication of Response Document
5/16/2013
More...
|
Santarus Inc. (SNTS) Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Secondary Common Stock Offering
5/16/2013
More...
|
Merck & Co., Inc. (MRK) Prices $ 6.5 Billion Debt Offering
5/16/2013
More...
|
Rockwell Medical Technologies (RMTI) Prices $35.0 Million Public Offering of Common Stock
5/15/2013
More...
|
VIVUS, Inc. (VVUS) Announces Proposed Offering of Convertible Senior Notes
5/15/2013
More...
|
Discovery Laboratories (DSCO) Announces Completion of $14.25 Million Public Offering
5/15/2013
More...
|
Fibrocell Science, Inc. Announces Approval of Common Stock Listing on NYSE MKT
5/15/2013
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) Prices Public Offering of Common Stock
5/15/2013
More...
|
Sucampo Pharmaceuticals, Inc. (SCMP) to be Added to the NASDAQ Biotechnology Index
5/15/2013
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) Announces Proposed Public Offering of Common Stock
5/15/2013
More...
|
BioAmber Inc. Announces Closing of Initial Public Offering
5/15/2013
More...
|
TopoTarget A/S Release: Shareholder Meetings in Copenhagen and Aarhus
5/14/2013
More...
|
Synergy Pharmaceuticals Added to NASDAQ Biotechnology Index
5/14/2013
More...
|
RegeneRx Biopharmaceuticals, Inc. (RGRX) Issues Letter to Sharholders
5/14/2013
More...
|
Omeros Corporation (OMER) Announces Closing of $16.2 Million Registered Direct Offering of Common Stock
5/14/2013
More...
|
SIGA Technologies, Inc. (SIGA) Announces Restatement of Certain Historical Financial Results to Reflect Reclassification of Warrants as a Liability
5/13/2013
More...
|
Warner Chilcott, PLC (WCRX) Release: Announcement Under Irish Takeover Rules Relevant Securities in Issue
5/13/2013
More...
|
Discovery Laboratories (DSCO) Announces Proposed Public Offering of Common Stock
5/10/2013
More...
|
Omeros Corporation (OMER) Announces $16.2 Million Registered Direct Offering of Common Stock
5/10/2013
More...
|
Pain Therapeutics (PTIE) Files Form 8-K Regarding Correspondence From Pfizer Inc. (PFE)
5/10/2013
More...
|
BioAmber Inc. Announces Pricing of Initial Public Offering
5/10/2013
More...
|
Karolinska Development AB - Interim Report January - March 2013
5/10/2013
More...
|
NeoStem, Inc. Clarification: No New Securities Being Issued
5/10/2013
More...
|
Santarus Inc. (SNTS) Announces Launch of a Proposed Secondary Common Stock Offering by a Selling Stockholder
5/10/2013
More...
|
Aceto Corporation Board of Directors Declares Quarterly Cash Dividend
5/10/2013
More...
|
NeoStem, Inc. CEO's Letter to Shareholders
5/10/2013
More...
|
Oxygen Biotherapeutics, Inc. (OXBO) Announces 20:1 Reverse Stock Split Effective After Market Close on May 10th
5/10/2013
More...
|
Santarus Inc. (SNTS) Announces Pricing of Secondary Common Stock Offering by a Selling Stockholder
5/10/2013
More...
|
Immunotech Laboratories Corporate Shareholder Update Summary
5/9/2013
More...
|
AEterna Zentaris (AEZS) Announces Election of Directors at Its Annual Meeting of Shareholders
5/9/2013
More...
|
MethylGene Announces Plan to Reincorporate in the United States as Mirati Therapeutics, Inc. and List on the NASDAQ
5/9/2013
More...
|
Receptos Announces Pricing of Initial Public Offering of Common Stock
5/9/2013
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) and ANI Pharmaceuticals, Inc. Announce Special Meetings of Stockholders to Consider Proposed Merger
5/9/2013
More...
|
Sonomax Technologies Announces Listing on the CNSX
5/9/2013
More...
|
IntelGenx Corp. Security Holders Approved the Amendment of the 2006 Stock Option Plan
5/9/2013
More...
|
Isis Pharmaceuticals, Inc. (ISIS) Prices Public Offering of Common Stock
5/9/2013
More...
|
Zealand Pharma Announces Amendments to its Articles of Association
5/8/2013
More...
|
Notice of Zealand Pharma ’s Interim Report for Q1 2013
5/8/2013
More...
|
Isis Pharmaceuticals, Inc. (ISIS) Announces Proposed Public Offering of Common Stock
5/8/2013
More...
|
Bayer HealthCare (BAY) Commences Cash Tender Offer for All Outstanding Shares of Conceptus, Inc. (CPTS)
5/8/2013
More...
|
Sigma-Aldrich Corporation (SIAL) Declares $0.215 Per Share Quarterly Dividend
5/8/2013
More...
|
GW Pharmaceuticals Announces the Closing of Its Initial Public Offering on the Nasdaq Global Market
5/8/2013
More...
|
Warner Chilcott, PLC (WCRX) Declares Semi-Annual Cash Dividend of $0.25 Per Share
5/8/2013
More...
|
DiaGenic ASA: Increase in Share Capital
5/8/2013
More...
|
Idera Pharmaceuticals, Inc. (IDRA) Announces Closing of Common Share Offering
5/8/2013
More...
|
Nuvo Research Inc. (NRI.TO) to Complete Share Consolidation
5/7/2013
More...
|
Karolinska Development AB - Interim Report January - March, Invitation to Conference Call Friday, May 10
5/7/2013
More...
|
INSYS Therapeutics Announces Closing of IPO and Exercise of Underwriters' Over-Allotment Option
5/7/2013
More...
|
Adamis Pharmaceuticals CEO Provides Update for Shareholders
5/6/2013
More...
|
Lignol Provides Addional Funding to Territory Biofuels Limited to Obtain Fully Diluted Majority Interest
5/6/2013
More...
|
Change in the Number of Votes Relating to BioTie Therapies Corp.'s Shares
5/6/2013
More...
|
PledPharma Appoints Advisor for the Commercialization of PledOx®
5/6/2013
More...
|
Novo Nordisk A/S (NVO) - Share Repurchase Program
5/6/2013
More...
|
3SBio Inc. (SSRX) Schedules Take-Private Vote for May 24
5/3/2013
More...
|
LipoScience, Inc. to Release First Quarter Fiscal Year 2013 Financial Results
5/3/2013
More...
|
Myriad Genetics, Inc. (MYGN) Announces 2013 Analyst and Investor Day
5/3/2013
More...
|
Kythera Biopharmaceuticals to Release First Quarter 2013 Operating Results
5/3/2013
More...
|
ChemoCentryx, Inc. (CCXI) to Hold First Quarter 2013 Financial Results Conference Call on Monday, May 13, 2013
5/3/2013
More...
|
PRANA Biotechnology (PRAN) Announces Share Purchase Plan Closed
5/3/2013
More...
|
Sanofi (France) (SAN.PA): Q1 2013 Business EPS(1) Impacted by Exclusivity Losses in Prior Year
5/2/2013
More...
|
3SBio Inc. (SSRX) Files Annual Report on Form 20-F for Fiscal Year 2012
5/2/2013
More...
|
Merck & Co., Inc. (MRK) Sales Disappoint; Company Cuts Profit Outlook
5/1/2013
More...
|
Sinovac Biotech Ltd. (SVA) Files Annual Report on Form 20-F
5/1/2013
More...
|
DW Healthcare Partners Invests in Med-Pharmex, Inc.
5/1/2013
More...
|
Stock House Group Report Initiates Coverage on Plandai Biotechnology, Inc. (PLPL.OB)
5/1/2013
More...
|
Coronado Biosciences to Report First Quarter 2013 Financial Results
5/1/2013
More...
|
Polydex Pharmaceuticals (POLXF) Reports Strong Backlog Resulting From Worldwide Increase in Demand for Product in 2013 Fiscal Year End Financial Results
5/1/2013
More...
|
NeoStem, Inc. Announces Partial Exercise of Underwriters' Over-Allotment Option
5/1/2013
More...
|
Idenix Pharmaceuticals, Inc. (IDIX) Reports First Quarter 2013 Financial Results
5/1/2013
More...
|
Mela Sciences (MELA) Announces First Quarter 2013 Financial Results
5/1/2013
More...
|
Amyris, Inc. Reports First Quarter 2013 Financial Results
5/1/2013
More...
|
Chrontech Pharma AB Receives Extended Offer From a Group of Shareholder
4/30/2013
More...
|
NYSE Liffe Lists Equity Options on Galapagos NV (GLPG.BR)
4/30/2013
More...
|
Novo Nordisk A/S (NVO) - Share Repurchase Program
4/30/2013
More...
|
Total Number of Voting Rights and Share Capital in Novo Nordisk A/S (NVO) as of 30 April 2013
4/30/2013
More...
|
Techne Corp. (TECH) Declares Dividend
4/30/2013
More...
|
Merrimack Pharmaceuticals Inc. Announces Timing of First Quarter 2013 Investor Conference Call
4/30/2013
More...
|
Momenta Pharmaceuticals, Inc. (MNTA) Reports First Quarter 2013 Financial Results
4/30/2013
More...
|
Cleveland Biolabs Inc. (CBLI) to Report First Quarter 2013 Financial Results and Provide Operational Update on May 9
4/30/2013
More...
|
Medical Marijuana, Inc. Shareholder Update and Letter
4/30/2013
More...
|
Aegerion Pharmaceuticals, Inc. (AEGR) Announces First-Quarter 2013 Financial Results
4/30/2013
More...
|
Bioniche Life Sciences Inc. (BNC) Acknowledges Request for Shareholder Meeting
4/29/2013
More...
|
GENFIT Corp. (ALGFT): Conversions Into Shares of 30 Bonds OCA2012-2
4/29/2013
More...
|
iBio, Inc. (IBIO) Closes $4.2 Million Public Offering and Terminates at-the-Market Offering
4/29/2013
More...
|
Neovasc Inc. (NVC) Reports Financial Results for 2012 Year-End
4/29/2013
More...
|
Galapagos NV (GLPG.BR) Completes Private Placement by Issuance of 2,696,831 New Ordinary Shares
4/29/2013
More...
|
Digirad Corporation (DRAD) Urges Stockholders to Vote the WHITE Proxy Card to Support Digirad's Director Nominees
4/26/2013
More...
|
Anacor Pharmaceuticals, Inc. (ANAC) Prices $20 Million Public Offering of Common Stock
4/26/2013
More...
|
Biotage AB (BIOTa.ST) Launches Share Buy-Back
4/26/2013
More...
|
Supernus Pharmaceuticals (SUPN) Prices Offering of $75 Million of 7.50% Convertible Senior Secured Notes Due 2019
4/26/2013
More...
|
PURE Bioscience (PURE) Receives Favorable NASDAQ Listing Decision
4/25/2013
More...
|
Nuvilex Price Valuation Justifies Investors' Confidence in Biotech
4/25/2013
More...
|
3SBio Inc. (SSRX) Adjourns Extraordinary General Meeting of Shareholders
4/25/2013
More...
|
Pfizer Inc. (PFE) Hosts Annual Meeting of Shareholders
4/25/2013
More...
|
Galapagos NV (GLPG.BR) to Raise Capital Via a Private Placement of New Shares
4/24/2013
More...
|
Haemonetics Corporation (HAE) Sets Date for Investor/Analyst Meeting
4/24/2013
More...
|
DURECT Corporation (DRRX) Invites You to Join Its First Quarter 2013 Earnings Conference Call
4/24/2013
More...
|
Navidea Biopharmaceuticals (NAVB) Announces Underwritten Sale of Common Stock
4/24/2013
More...
|
Pain Therapeutics (PTIE) Reports Q1 2013 Financial Results
4/24/2013
More...
|
Sagent Pharmaceuticals, Inc. Sets Date and Time for Release of First Quarter 2013 Financial Results
4/24/2013
More...
|
iBio, Inc. (IBIO) Prices $4.2 Million Public Offering
4/23/2013
More...
|
Medicago, Inc. Announces a $3.5 Million Private Placement
4/23/2013
More...
|
iBio, Inc. (IBIO) Announces Proposed Public Offering
4/23/2013
More...
|
Novo Nordisk A/S (NVO) - Share Repurchase Program
4/22/2013
More...
|
Novo Nordisk A/S (NVO): Reduction of the Share Capital
4/22/2013
More...
|
Ablynx Announces Warrant Exercise
4/22/2013
More...
|
MorphoSys AG to Start Share Buy-Back Program
4/22/2013
More...
|
TherapeuticsMD, Inc. Announces Trading of Its Common Stock on the NYSE MKT Under Symbol "TXMD"
4/22/2013
More...
|
CorMedix (CRMD) Granted Extension of NYSE MKT Listing
4/22/2013
More...
|
Endocyte, Inc. (ECYT) Announces First Quarter 2013 Earnings Conference Call
4/19/2013
More...
|
Victory Park Capital Completes Public Auction of Unigene Laboratories, Inc. (UGNE)'s Peptelligence™ Drug Delivery Platform
4/18/2013
More...
|
Siegfried's Annual Shareholders Meeting Approves All Proposals
4/18/2013
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
4/18/2013
More...
|
Agenus (Formerly known as Antigenics Inc. - Lexington, MA) (AGEN) to Report First Quarter 2013 Financial Results on April 24, 2013; Conference Call to Follow
4/18/2013
More...
|
Elan Corporation PLC (ELN) Announces Final Results of Its Tender Offer
4/18/2013
More...
|
Targeted Medical Pharma Announces Registration Statement
4/18/2013
More...
|
Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
4/17/2013
More...
|
Lignol Announces 40% Stake in Territory Biofuels Limited
4/17/2013
More...
|
Trading in Theravance, Inc. (THRX) Common Stock Halted
4/17/2013
More...
|
Ablynx: Publication in Accordance With Article 14 of the Belgian Law of 2 May 2007 Regarding the Publication of Major Shareholdings (the "Transparency Law")
4/17/2013
More...
|
Recordati S.p.A: Shareholders Approve the 2012 Accounts. Dividend EUR 0.30 Per Share
4/17/2013
More...
|
Abiomed (ABMD) Announces Preliminary Fourth Quarter Revenue of $43.7 Million, Driven by Record Number of Patients Supported
4/17/2013
More...
|
WuXi PharmaTech Co., Ltd. Files 2012 Annual Report on Form 20-F
4/17/2013
More...
|
MorphoSys AG: Announcement of the Convening of the AGM in Munich/Germany on 4 June 2013 According to Sec. 121 Para. 4a AktG With the Objective of Europe-Wide Distribution
4/16/2013
More...
|
The Special Committee of China Shenghuo Pharmaceutical Holdings, Inc. Accepts Going Private Proposal From Lan's Int'l Medicine Investment Co., Limited at $0.16 per Share to be Effected Through a Reverse Stock Split
4/16/2013
More...
|
Gestion Notify of 4.97% Shareholding in Galapagos NV (GLPG.BR)
4/15/2013
More...
|
Novo Nordisk A/S (NVO) - Share Repurchase Program
4/15/2013
More...
|
BioRestorative Therapies, Inc. Announces One-for-Fifty Reverse Stock Split
4/15/2013
More...
|
CorMedix (CRMD) Notified of NYSE MKT Listing Deficiency
4/12/2013
More...
|
Actavis to Host First Quarter 2013 Earnings Conference Call and Webcast
4/11/2013
More...
|
Boston Scientific Corporation (BSX) to Webcast Conference Call Discussing First Quarter 2013 Financial Results on April 25
4/11/2013
More...
|
Incyte Corporation (INCY) to Report First Quarter 2013 Financial Results on May 2
4/11/2013
More...
|
IGI Laboratories, Inc. to Hold Conference Call for 1st Quarter 2013 Results
4/11/2013
More...
|
Webcast Alert: Heska Corporation (HSKA) Announces First Quarter 2013 Earnings Conference Call Webcast
4/11/2013
More...
|
Cardinal Health, Inc. (CAH) to Release Third-Quarter Results For Fiscal Year 2013 on May 2
4/11/2013
More...
|
Medical Marijuana, Inc. Reports Record First Quarter 2013 Revenue and Income
4/11/2013
More...
|
Alexion Pharmaceuticals Inc. (ALXN) to Report First Quarter 2013 Results on Thursday, April 25, 2013
4/11/2013
More...
|
TRT Chinese Medicines Expects to IPO on ChiNext
4/11/2013
More...
|
Sangamo BioSciences, Inc. (SGMO) Announces Presentation at Regen Med Investor Day
4/11/2013
More...
|
AptarGroup Declares Quarterly Dividend; Confirms First Quarter Conference Call
4/11/2013
More...
|
Active Biotech AB (BTPC) - Notice of Annual General Meeting of Shareholders
4/11/2013
More...
|
Sunshine Heart Prices $13.1 Million Public Offering of Common Shares
4/11/2013
More...
|
OXiGENE (OXGN) Announces $5 Million Private Placement
4/11/2013
More...
|
Active Biotech AB (BTPC) - Notice of Annual General Meeting of Shareholders
4/11/2013
More...
|
Teva Pharmaceutical Industries Limited (TEVA) to Report First Quarter 2013 Financial Results on May 2, 2013
4/10/2013
More...
|
Hill-Rom Holdings, Inc. to Host Investor Conference May 7
4/10/2013
More...
|
WuXi PharmaTech Co., Ltd. Schedules First-Quarter 2013 Earnings Release
4/10/2013
More...
|
Charles River Laboratories (Massachusetts) Schedules First-Quarter 2013 Earnings Release and Conference Call
4/9/2013
More...
|
Biostar Pharmaceuticals, Inc. (BSPM) to Host Fiscal 2012 Year End Earnings Conference Call on Monday, April 15, 2013 at 9:30 a.m. ET
4/9/2013
More...
|
Mylan Inc. (MYL) Schedules First Quarter 2013 Financial Results Conference Call and Live Webcast
4/9/2013
More...
|
NxStage Medical, Inc. (NXTM) to Report First Quarter Fiscal 2013 Financial Results
4/9/2013
More...
|
Hadasit Bio-Holdings Ltd. (HDST) CEO Letter to Shareholders
4/9/2013
More...
|
Organovo Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
4/9/2013
More...
|
Northwest Biotherapeutics (NWBT) 2012 Annual Report Shows Strong Progress and Enhancement of Leadership Position
4/9/2013
More...
|
Galapagos NV (GLPG.BR) Increases Share Capital Through Warrant Exercises
4/9/2013
More...
|
Illumina, Inc. (ILMN) to Announce First Quarter 2013 Financial Results on Monday, April 22, 2013
4/8/2013
More...
|
AmerisourceBergen Corporation (ABC) Announces Date and Time for Fiscal Second Quarter Earnings Release
4/8/2013
More...
|
AbbVie (ABBV) to Host First-Quarter Earnings Conference Call
4/8/2013
More...
|
Novo Nordisk A/S (NVO) - Share Repurchase Program
4/8/2013
More...
|
Oragenics, Inc. (OGEN) Announces Approval of Common Stock Listing on NYSE MKT
4/8/2013
More...
|
InVivo Therapeutics Corporation (NVIV) Announces Warrant Exchange Offer With Intent to Up-List to a National Securities Exchange
4/8/2013
More...
|
Becton, Dickinson and Company (BDX) Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
4/8/2013
More...
|
Cepheid (CPHD) Schedules 2013 First Quarter Results Announcement and Webcast
4/5/2013
More...
|
Anika Therapeutics (ANIK) Announces Date of First-Quarter 2013 Financial Results Conference Call
4/5/2013
More...
|
Sigma-Aldrich Corporation (SIAL) Announces Q1 2013 Earnings Conference Call
4/5/2013
More...
|
Medical Marijuana, Inc., Corporate Update- Significant Revenue and Net Income Growth 1st Quarter- Division and Corporate Holdings Update
4/5/2013
More...
|
Cardium Therapeutics, Inc. (CXM) Announces $4.0 Million Preferred Stock Financing and Reports on Exchange Listing Compliance
4/5/2013
More...
|
Pacira Pharmaceuticals, Inc. to Close the NASDAQ Stock Market on April 8, 2013
4/5/2013
More...
|
Eli Lilly and Company (LLY) Confirms Date and Conference Call for First-Quarter 2013 Financial Results Announcement
4/4/2013
More...
|
Organovo Holdings, Inc. Announces Change of Fiscal Year
4/4/2013
More...
|
Generex Comments on Results of Stockholders' Meeting
4/4/2013
More...
|
Emergent BioSolutions (EBS) to Release First Quarter 2013 Financial Results and Conduct a Conference Call on May 2, 2013
4/4/2013
More...
|
ResMed Inc. (RMD) Announces Conference Call and Webcast to Discuss Third Quarter 2013 Results
4/4/2013
More...
|
PAREXEL International (PRXL) Announces Date of Third Quarter Fiscal Year 2013 Earnings Release and Conference Call
4/3/2013
More...
|
La Jolla Pharmaceutical Company (LJPC) Announces Start of Common Stock Quotation on OTCBB
4/3/2013
More...
|
Elan Corporation PLC (ELN) Announces Redemption of Its Senior Notes Due 2019
4/3/2013
More...
|
Valeant Pharmaceuticals International (VRX) and Obagi Medical Products, Inc. (OMPI) Agree on an Increased Offer Price of $24.00 Per Share in Cash
4/3/2013
More...
|
Haemonetics Corporation (HAE) Sets Date for Fourth Quarter Fiscal Year 2013 Earnings Release: Wednesday, May 1, 2013
4/2/2013
More...
|
Novo Nordisk A/S (NVO) - Share Repurchase Program
4/2/2013
More...
|
Novo Nordisk A/S (NVO)'s Holding of Its Own Shares (31 March 2013)
4/2/2013
More...
|
Sinovac Biotech Ltd. (SVA) Schedules Conference Call and Webcast for Fourth Quarter and Full Year Unaudited Financial Results
4/2/2013
More...
|